Navigation Links
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
Date:9/9/2008

f cell and tissue therapy products. These products include:

-- The BioArchive(R) System, an automated cryogenic device, is used by cord blood stem cell banks in more than 25 countries for cryopreserving and archiving cord blood stem cell units for transplant.

-- AXP(TM) AutoXpress Platform (AXP(TM)) is a proprietary family of automated devices that includes the AXP and the MarrowXpress(TM) and companion sterile blood processing disposable for harvesting stem cells in a closed system. The AXP device is used for the processing of cord blood. GE Healthcare is the exclusive global distribution partner for the AXP cord blood product except for Central and South America, China and Russia/CIS, where ThermoGenesis markets through independent distributors. The MarrowXpress is used for isolating stem cells from bone marrow. ThermoGenesis sells the MarrowXpress directly to global customers.

-- The CryoSeal(R) FS System, an automated device and companion sterile blood processing disposable, is used to prepare fibrin sealants from plasma in about an hour. The CryoSeal FS System is approved in the U.S. for liver resection surgeries. The CryoSeal FS System has received the CE-Mark which allows sales of the product throughout the European community. Asahi Medical is the exclusive distributor for the CryoSeal System in Japan and the Company markets through independent distributors in Europe and South America.

-- The Thrombin Processing Device(TM) (TPD(TM)) is a sterile blood processing disposable that prepares activated thrombin from a small aliquot of plasma in less than 30 minutes. The CE-Marked TPD is currently being marketed in Europe by Biomet, Inc., subsidiary Biomet Biologics, Medtronic, Inc. and independent distributors.

This press release contains forward-looking statements, and such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncerta
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
2. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
3. ThermoGenesis Names Tiffany Olson to Board of Directors
4. ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
5. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
6. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
7. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
8. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
9. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
10. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
11. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... announces that a new market research report ... Neurostimulation - A Global Market Perspective ... world neurostimulation market stands enthused by the ... resultant rise in age-related diseases such as, ...
(Date:12/2/2009)... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today ... and dosimetry trial of Cotara® in patients with relapsed ... Cotara is a targeted monoclonal antibody linked to ... for GBM. Cotara specifically targets cells at the ...
(Date:12/2/2009)... Cell announced today,a feasibility study evaluating the preclinical ... product which combines technology from Weill,Cornell Medical College ... to,treat inherited anemias such as Cooley,s Anemia. , ... a series of technologies to expand, ex vivo,populations ...
(Date:12/2/2009)... going through,extraordinary times; markets are in turmoil and uncertainty ... that the pharma industry has been,relatively immune to the ... During the midst of the difficult ... an R&D center in Shanghai, the largest of,its kind ...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
... 5 Genta,Incorporated (OTC Bulletin Board: GNTA) announced today ... institutional and accredited,investors to place Senior Secured Convertible ... million in gross proceeds before fees and expenses. ... is expected to take place on or,about June ...
... Pa., June 5 ViroPharma Incorporated,(Nasdaq: VPHM ) notes ... its,Advisory Committee for Pharmaceutical Science and Clinical Pharmacology to,be held ... at this,meeting, including a discussion of:, " ... ... bioequivalence methods for locally acting drugs that treat ...
... Research Associates, LLC,announced today that it has issued ... (AAH: ASX). The full 56-page report can,be found ... Ltd. ("Arana" or "the Company") is a biotechnology,company ... cancer. Arana,s business is divided into two,sectors: (1) ...
Other Biology Technology:Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs 2Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs 3Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs 4Viropharma Comments On Upcoming FDA Advisory Committee Meeting 2Viropharma Comments On Upcoming FDA Advisory Committee Meeting 3Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd. 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd. 3
(Date:12/4/2009)... This release is available in German . ... Biology of Ageing could help to understand the positive effect ... organisms (fruit flies and mice) have shown that dietary restriction ... diminished fertility. So the female fruit fly reproduces less frequently ...
(Date:12/3/2009)... co-workers discovered that specific types of human papillomavirus (HPV) ... pathogens cause cells to degenerate. It is known today ... E7. Both proteins switch off different cellular control functions, ... Rsl and his co-workers at DKFZ have now discovered ...
(Date:12/3/2009)... message: , , Preliminary Press Conference Topics, ... of Sciences museum, Attention PIOs: Sending Press Releases ... deadline 10 December, News Media registration information , ... 7 December, Who,s coming, , For important ...
Breaking Biology News(10 mins):How nutrition affects healthy aging 2Papillomavirus silences innate immune response 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Video 3A National Minority Quality Forum Launches First U S HIV AIDS Atlas 49648 1Video 3A National Minority Quality Forum Launches First U S HIV AIDS Atlas 49648 2Video 3A National Minority Quality Forum Launches First U S HIV AIDS Atlas 49648 3MapHIV org Shows Massachusetts Suffolk County Seriously Impacted by HIV and AIDS 49645 1MapHIV org Shows Massachusetts Suffolk County Seriously Impacted by HIV and AIDS 49645 2MapHIV org Shows Massachusetts Suffolk County Seriously Impacted by HIV and AIDS 49645 3MapHIV org Shows 18 25 of Georgias Counties are Seriously Impacted by HIV 49642 1MapHIV org Shows 18 25 of Georgias Counties are Seriously Impacted by HIV 49642 2MapHIV org Shows 18 25 of Georgias Counties are Seriously Impacted by HIV 49642 3
... University of Malaya (UM) today announced the establishment of ... is the first Centre of its kind in improving ... in terms of their diet and disease, conducting research ... and health, providing assistance for the national cancer registry ...
... Observatory of Singapore (EOS) which aspires to be ... several of civilisation,s most serious environmental threats ... aims to provide invaluable research and data, ... potentially save hundreds of thousands of lives. ...
... ocean bubbles up naturally from the seafloor, with Earth giving ... NASA satellites collect thousands of images and 1.5 terrabytes of ... because no one thinks there is a use for it. ... an otherwise undistinguished mass of ocean imagery. Chuanmin Hu, an ...
Other Biology News:Queen's University Belfast improves Malaysian public health 2The Earth Observatory of Singapore devoted to the study of earth sciences officially opens 2The Earth Observatory of Singapore devoted to the study of earth sciences officially opens 3Scientists find black gold amidst overlooked data 2Scientists find black gold amidst overlooked data 3
Human peripheral blood PBMCs, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Human peripheral blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Umbilical cord blood mononuclear cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Human plasmacytoid dendritic cells, BDCA-4+, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Biology Products: